Australia Cell and Gene Therapy Market Size, Share, Trends and Forecast by Therapy Type, Indication, Delivery Mode, End User, and Region, 2025-2033

Australia Cell and Gene Therapy Market Size, Share, Trends and Forecast by Therapy Type, Indication, Delivery Mode, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A32737

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Australia Cell and Gene Therapy Market - Introduction

4.1    Overview
4.2    Market Dynamics
4.3    Industry Trends
4.4    Competitive Intelligence
5    Australia Cell and Gene Therapy Market Landscape
5.1    Historical and Current Market Trends (​​​​2019-2024​)
5.2    Market Forecast (​​​​​2025-2033​)
6    Australia Cell and Gene Therapy Market - Breakup by Therapy Type
6.1    Cell Therapy
6.1.1    Overview
6.1.2    Historical and Current Market Trends (​​​​2019-2024​)
6.1.3    Market Segmentation
6.1.3.1    Stem Cell
6.1.3.1.1    Pluripotent Stem Cell
6.1.3.1.2    Cancer Stem Cell
6.1.3.1.3    Adult Stem Cell
6.1.3.2    Non-Stem Cell
6.1.3.2.1    T-Cell
6.1.3.2.2    Natural Killer Cell
6.1.3.2.3    Others
6.1.4    Market Forecast (​​​​​2025-2033​)
6.2    Gene Therapy
6.2.1    Overview
6.2.2    Historical and Current Market Trends (​​​​2019-2024​)
6.2.3    Market Forecast (​​​​​2025-2033​)
7    Australia Cell and Gene Therapy Market - Breakup by Indication
7.1    Cardiovascular Disease
7.1.1    Overview
7.1.2    Historical and Current Market Trends (​​​​2019-2024​)
7.1.3    Market Forecast (​​​​​2025-2033​)
7.2    Oncology Disorder
7.2.1    Overview
7.2.2    Historical and Current Market Trends (​​​​2019-2024​)
7.2.3    Market Forecast (​​​​​2025-2033​)
7.3    Genetic Disorder
7.3.1    Overview
7.3.2    Historical and Current Market Trends (​​​​2019-2024​)
7.3.3    Market Forecast (​​​​​2025-2033​)
7.4    Infectious Disease
7.4.1    Overview
7.4.2    Historical and Current Market Trends (​​​​2019-2024​)
7.4.3    Market Forecast (​​​​​2025-2033​)
7.5    Neurological Disorder
7.5.1    Overview
7.5.2    Historical and Current Market Trends (​​​​2019-2024​)
7.5.3    Market Forecast (​​​​​2025-2033​)
7.6    Others
7.6.1    Historical and Current Market Trends (​​​​2019-2024​)
7.6.2    Market Forecast (​​​​​2025-2033​)
8    Australia Cell and Gene Therapy Market - Breakup by Delivery Mode
8.1    In-Vivo
8.1.1    Overview
8.1.2    Historical and Current Market Trends (​​​​2019-2024​)
8.1.3    Market Forecast (​​​​​2025-2033​)
8.2    Ex-Vivo
8.2.1    Overview
8.2.2    Historical and Current Market Trends (​​​​2019-2024​)
8.2.3    Market Forecast (​​​​​2025-2033​)
9    Australia Cell and Gene Therapy Market - Breakup by End User
9.1    Hospitals
9.1.1    Overview
9.1.2    Historical and Current Market Trends (​​​​2019-2024​)
9.1.3    Market Forecast (​​​​​2025-2033​)
9.2    Cancer Care Centers
9.2.1    Overview
9.2.2    Historical and Current Market Trends (​​​​2019-2024​)
9.2.3    Market Forecast (​​​​​2025-2033​)
9.3    Pharmaceutical and Biotechnology Companies
9.3.1    Overview
9.3.2    Historical and Current Market Trends (​​​​2019-2024​)
9.3.3    Market Forecast (​​​​​2025-2033​)
9.4    Others
9.4.1    Historical and Current Market Trends (​​​​2019-2024​)
9.4.2    Market Forecast (​​​​​2025-2033​)
10    Australia Cell and Gene Therapy Market – Breakup by Region
10.1    Australia Capital Territory & New South Wales
10.1.1    Overview
10.1.2    Historical and Current Market Trends (​​​​2019-2024​)
10.1.3    Market Breakup by Therapy Type
10.1.4    Market Breakup by Indication
10.1.5    Market Breakup by Delivery Mode
10.1.6    Market Breakup by End User
10.1.7    Key Players
10.1.8    Market Forecast (​​​​​2025-2033​)
10.2    Victoria & Tasmania
10.2.1    Overview
10.2.2    Historical and Current Market Trends (​​​​2019-2024​)
10.2.3    Market Breakup by Therapy Type
10.2.4    Market Breakup by Indication
10.2.5    Market Breakup by Delivery Mode
10.2.6    Market Breakup by End User
10.2.7    Key Players
10.2.8    Market Forecast (​​​​​2025-2033​)
10.3    Queensland
10.3.1    Overview
10.3.2    Historical and Current Market Trends (​​​​2019-2024​)
10.3.3    Market Breakup by Therapy Type
10.3.4    Market Breakup by Indication
10.3.5    Market Breakup by Delivery Mode
10.3.6    Market Breakup by End User
10.3.7    Key Players
10.3.8    Market Forecast (​​​​​2025-2033​)
10.4    Northern Territory & Southern Australia
10.4.1    Overview
10.4.2    Historical and Current Market Trends (​​​​2019-2024​)
10.4.3    Market Breakup by Therapy Type
10.4.4    Market Breakup by Indication
10.4.5    Market Breakup by Delivery Mode
10.4.6    Market Breakup by End User
10.4.7    Key Players
10.4.8    Market Forecast (​​​​​2025-2033​)
10.5    Western Australia
10.5.1    Overview
10.5.2    Historical and Current Market Trends (​​​​2019-2024​)
10.5.3    Market Breakup by Therapy Type
10.5.4    Market Breakup by Indication
10.5.5    Market Breakup by Delivery Mode
10.5.6    Market Breakup by End User
10.5.7    Key Players
10.5.8    Market Forecast (​​​​​2025-2033​)
11    Australia Cell and Gene Therapy Market – Competitive Landscape
11.1    Overview
11.2    Market Structure
11.3    Market Player Positioning
11.4    Top Winning Strategies
11.5    Competitive Dashboard
11.6    Company Evaluation Quadrant
12    Profiles of Key Players
12.1    Company A 
12.1.1    Business Overview
12.1.2    Services Offered
12.1.3    Business Strategies
12.1.4    SWOT Analysis
12.1.5    Major News and Events
12.2    Company B
12.2.1    Business Overview
12.2.2    Services Offered
12.2.3    Business Strategies
12.2.4    SWOT Analysis
12.2.5    Major News and Events
12.3    Company C
12.3.1    Business Overview
12.3.2    Services Offered
12.3.3    Business Strategies
12.3.4    SWOT Analysis
12.3.5    Major News and Events
12.4    Company D 
12.4.1    Business Overview
12.4.2    Services Offered
12.4.3    Business Strategies
12.4.4    SWOT Analysis
12.4.5    Major News and Events
12.5    Company E
12.5.1    Business Overview
12.5.2    Services Offered
12.5.3    Business Strategies
12.5.4    SWOT Analysis
12.5.5    Major News and Events    

Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.

13    Australia Cell and Gene Therapy Market - Industry Analysis
13.1    Drivers, Restraints, and Opportunities
13.1.1    Overview
13.1.2    Drivers
13.1.3    Restraints
13.1.4    Opportunities
13.2    Porters Five Forces Analysis
13.2.1    Overview
13.2.2    Bargaining Power of Buyers
13.2.3    Bargaining Power of Suppliers
13.2.4    Degree of Competition
13.2.5    Threat of New Entrants
13.2.6    Threat of Substitutes
13.3    Value Chain Analysis
14    Appendix

Australia Cell and Gene Therapy Market Size, Share, Trends and Forecast by Therapy Type, Indication, Delivery Mode, End User, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials